This inventor holds 3 USPTO granted patents. Top assignees: Behringwerke Aktiengesellschaft, Chiron Corporation. Active years: 1992-1997.
Company Filing History:
3 out of 340 
1 out of 672 
Years Active: 1992-1997
Title: The Innovations of Eric-Paul Paques
Introduction
Eric-Paul Paques is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative polypeptide compositions. With a total of 3 patents to his name, his work has had a considerable impact on medical science.
Latest Patents
One of his latest patents focuses on a pharmaceutical for subcutaneous or intramuscular administration. This invention involves liquid pharmaceuticals containing a polypeptide and at least one amino acid, along with a process for their preparation. The use of an amino acid suitable for subcutaneous or intramuscular administration in a solution of a polypeptide is also described. Another significant patent involves peptide plasminogen activators. This patent presents novel polypeptide compositions based on the amino acid sequence of tissue plasminogen activator (tPA), which exhibit improved properties over natural tPA. These enhancements include increased specific activity and reduced inhibition by plasminogen activator inhibitors.
Career Highlights
Throughout his career, Eric-Paul Paques has worked with prominent companies in the pharmaceutical industry. Notable among these are Behringwerke Aktiengesellschaft and Chiron Corporation. His experience in these organizations has contributed to his expertise and innovative capabilities in the field.
Collaborations
Eric-Paul has collaborated with esteemed colleagues, including Werner Stuber and Ernest-Guenter Afting. These partnerships have likely fostered a rich exchange of ideas and advancements in their respective fields.
Conclusion
Eric-Paul Paques is a distinguished inventor whose work in pharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his contributions to the industry.